Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russian Federation.
Federal Research and Clinical Center of Physical-Chemical Medicine of the Federal Medical and Biological Agency, Moscow, 119435, Russian Federation.
Cell Death Dis. 2023 Feb 2;14(2):77. doi: 10.1038/s41419-022-05470-9.
Dysregulation of pre-mRNA splicing is a common hallmark of cancer cells and it is associated with altered expression, localization, and mutations of the components of the splicing machinery. In the last few years, it has been elucidated that spliceosome components can also influence cellular processes in a splicing-independent manner. Here, we analyze open source data to understand the effect of the knockdown of splicing factors in human cells on the expression and splicing of genes relevant to cell proliferation, migration, cell cycle regulation, DNA repair, and cell death. We supplement this information with a comprehensive literature review of non-canonical functions of splicing factors linked to cancer progression. We also specifically discuss the involvement of splicing factors in intercellular communication and known autoregulatory mechanisms in restoring their levels in cells. Finally, we discuss strategies to target components of the spliceosome machinery that are promising for anticancer therapy. Altogether, this review greatly expands understanding of the role of spliceosome proteins in cancer progression.
前体 mRNA 剪接的失调是癌细胞的一个常见特征,它与剪接机制组件的表达、定位和突变改变有关。在过去的几年中,已经阐明剪接体成分也可以以不依赖剪接的方式影响细胞过程。在这里,我们分析开放源数据,以了解在人类细胞中敲低剪接因子对与细胞增殖、迁移、细胞周期调控、DNA 修复和细胞死亡相关基因的表达和剪接的影响。我们还通过对与癌症进展相关的剪接因子的非典型功能的全面文献综述来补充这些信息。我们还特别讨论了剪接因子在细胞间通讯中的参与以及已知的自动调节机制,以恢复其在细胞中的水平。最后,我们讨论了针对剪接体机制组件的靶向治疗策略,这些策略在癌症治疗中具有广阔的前景。总的来说,这篇综述大大扩展了对剪接体蛋白在癌症进展中的作用的理解。